BTN3A3 and ovarian carcinoma: Human Protein Atlas (HPA) provides researchers with biomedical resources based on clinical pathology, from which we found that ovarian cancer patients with high expression of BTN3A3 had a longer survival (P = 0.00018) (Figure 1A), suggesting that BTN3A3 may play an important role in the occurrence and progression of ovarian cancer.